6 documents found, page 1 of 1

MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2-advance...

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzu...

Everolimus plus endocrine therapy for postmenopausal women with estrogen recept...

Efficacy and safety of Bevacizumab-Containing therapy in newly diagnosed ovaria...

A phase III, randomized, non-inferiority study comparing the efficacy and safet...

OBJECTIVES: To compare the efficacy and safety of two filgrastim formulations for controlling chemotherapy-induced neutropenia and to evaluate the non-inferiority of the test drug relative to the originator. METHODS: This phase III non-inferiority study had a randomized, multicenter, and open-label design. The patients were randomized at a ratio of 1:1 with a follow-up period of 6 weeks for each patient. In bot...

A phase 2 study of neoadjuvant goserelin and letrozole for premenopausal women ...